Perry Jennifer Scott 4
4 · BICYCLE THERAPEUTICS PLC · Filed Apr 6, 2026
Research Summary
AI-generated summary of this filing
Bicycle Therapeutics COO Jennifer Perry Sells Shares
What Happened
Jennifer Scott Perry, Chief Operating Officer of Bicycle Therapeutics plc (BCYC), sold a total of 1,408 shares in multiple open-market transactions between April 2 and April 6, 2026, generating roughly $6,962 in proceeds. Breakdown: 1,038 shares on 2026-04-02 at a weighted average price of $4.91 ($5,097), 37 shares on 2026-04-06 at $5.05 ($187), and 333 shares on 2026-04-06 at a weighted average of $5.04 (~$1,678). These were sales (not purchases), and at least one portion was a routine "sell to cover" for tax withholding.
Key Details
- Transaction dates and prices:
- 2026-04-02: 1,038 shares @ weighted avg $4.91 (~$5,097). Footnotes indicate this sale was to satisfy statutory tax withholding for RSU vesting (sell-to-cover) and was not a discretionary sale (F1, F2; price range reported $4.88–$4.98).
- 2026-04-06: 37 shares @ $5.05 (~$187).
- 2026-04-06: 333 shares @ weighted avg $5.04 (~$1,678). Filing notes this transaction was made under a pre-established Rule 10b5-1 trading plan (adopted March 27, 2025) and the weighted-price range was $5.035–$5.04 (F3, F4).
- Total proceeds across all sales: ≈ $6,962.
- Shares owned after the transactions: Not specified in the provided excerpt of the filing.
- Filing timeliness: Report filed 2026-04-06 for transactions on 2026-04-02 and 2026-04-06; filing appears timely (within required Form 4 reporting window).
- Footnote meanings: F1 = sell-to-cover for RSU tax withholding; F2/F4 = weighted-average price ranges for multi-trade sales; F3 = trade(s) executed under a Rule 10b5-1 plan.
Context
- Sell-to-cover transactions (like the 1,038-share sale) are routine when RSUs vest and typically required by award agreements to satisfy tax withholding; they do not necessarily signal the insider's view on the company's prospects.
- Sales executed under a Rule 10b5-1 plan are pre-arranged and are generally considered automated trades rather than discretionary timing by the insider.
- Overall dollar value is small (~$7k), so these transactions are routine in size and not a large insider divestment.
Insider Transaction Report
Form 4
Perry Jennifer Scott
Chief Operating Officer
Transactions
- Sale
Ordinary Shares
[F1][F2]2026-04-02$4.91/sh−1,038$5,097→ 92,834 total - Sale
Ordinary Shares
[F1]2026-04-06$5.05/sh−37$187→ 92,797 total - Sale
Ordinary Shares
[F3][F4]2026-04-06$5.04/sh−333$1,678→ 92,464 total
Footnotes (4)
- [F1]Represents the number of shares required to be sold to cover the statutory tax withholding obligations in connection with the vesting and settlement of the RSUs. This sale is mandated by the Reporting Person's award agreement that requires the satisfaction of minimum statutory tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary sale by the Reporting Person.
- [F2]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $4.88 to $4.98 inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes (2) and (4).
- [F3]This transaction was made pursuant to a Rule 10b5-1 trading plan adopted on March 27, 2025.
- [F4]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $5.035 to $5.04 inclusive.
Signature
/s/ Travis Thompson, Attorney-in-Fact|2026-04-06